Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2012
12/20/2012WO2012173710A1 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012WO2012173371A2 Novel compounds and organic electronic device using same
12/20/2012WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
12/20/2012WO2012172449A1 Lactams as beta secretase inhibitors
12/20/2012WO2012172368A1 Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
12/20/2012WO2012172093A1 Dihydroindolizine derivate as metabotropic glutamate receptor modulators
12/20/2012WO2012148090A3 Production of diamine having a novel structure containing a terpyridine or phenanthroline functional group and a use therefor
12/20/2012US20120323010 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
12/20/2012US20120323009 Production method of reduced pyrroloquinoline quinone
12/20/2012US20120323006 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
12/20/2012US20120322821 Ghrelin receptor agonist for treatment of cachexia
12/20/2012US20120322816 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012US20120322806 Quinoxalinedione derivatives
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322791 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120321967 Ionic liquid containing sulfonate ions
12/20/2012US20120321559 Hexahydro-pyrrolo-isoquinoline compounds
12/20/2012US20120319099 Material for organic electroluminescence devices and organic electroluminescence device using the material
12/20/2012US20120319087 Heterocyclic compound and organic light-emitting device containing same
12/20/2012CA2850137A1 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
12/20/2012CA2837268A1 Compositions and methods for modulating a kinase
12/19/2012EP2535336A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
12/19/2012EP2535329A2 Spiro-piperidine derivatives
12/19/2012EP2534152A1 Macrocycles as factor xia inhibitors
12/19/2012EP2534147A1 Spiroheterocyclical substituted tetramic acid derivatives
12/19/2012EP2533640A1 Processes of synthesizing dihydropyridophthalazinone derivatives
12/19/2012CN102834397A Macrocycles as factor xia inhibitors
12/19/2012CN102834395A Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
12/19/2012CN102834393A Apoptosis signal-regulating kinase 1 inhibitors
12/19/2012CN102834387A Phenylpyri(mi)dinylpyrazoles and their use as fungicides
12/19/2012CN102827186A Pyridino five-membered heterocyclic derivative as well as preparation method and applications thereof
12/19/2012CN102827164A Preparation method of hypoestestatin 1
12/19/2012CN102827163A Method for extracting tylophorine from tylophora florlbunda
12/19/2012CN102827162A Preparation method of 2-methyl-7-azaindole
12/19/2012CN102827161A Method for purifying moxifloxacin
12/19/2012CN102827160A PI3K or PI3K/m-TOR pathway inhibitor and pharmaceutical applications thereof
12/19/2012CN102827146A Fluoroquinolone acetal ftivazide as well as preparation method and application thereof
12/19/2012CN102827143A Novel synthetic method for fluoroquinolone and salts thereof
12/19/2012CN102827069A Method for preparing two organic compounds by using chlorogenic acid as raw material and application thereof
12/19/2012CN102827067A Beta-lactamase inhibitor
12/19/2012CN102276608B Method for synthesizing tetrahydro-beta-carboline diketopiperazine compound
12/19/2012CN102093356B Preparation method of 2-chlorine-5,6,7,8-tetrahydrogen-1,6-naphthyridine hydrochloride
12/19/2012CN101454320B Pyridine[3,4-b]pyrazinones
12/18/2012US8334387 Method for measuring aromatase activity
12/18/2012US8334386 Aqueous synthesis of perylene pigments
12/18/2012US8334385 Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
12/18/2012US8334380 Method for producing bicyclic guanidines by use of a cyclic urea and a dehydrating agent
12/18/2012US8334299 β-carboline for the treatment of neurodegenerative diseases
12/18/2012US8334236 Ring-fused 2-pyridone derivatives and herbicides
12/18/2012US8334029 Materials and methods for the preparation of anisotropically-ordered solids
12/18/2012CA2683956C Quinolones and azaquinolones that inhibit prolyl hydroxylase
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/18/2012CA2563575C Enantiomerically pure hexahydropyrrolocyclopentapyridine derivatives
12/18/2012CA2525502C Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/18/2012CA2504385C Thiadiazine compounds and uses thereof
12/17/2012CA2780403A1 Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
12/13/2012WO2012170759A1 Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
12/13/2012WO2012170554A1 N-biphenylmethylindole modulators of pparg
12/13/2012WO2012169649A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/13/2012WO2012168364A1 Apixaban preparation process
12/13/2012WO2012167733A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012167606A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof
12/13/2012WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses
12/13/2012WO2012167423A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012143080A3 Materials for organic electroluminescent devices
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316197 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316192 Substituted indolo [2,3-a] quinolizines
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316184 Novel microbicides
12/13/2012US20120316183 Novel solvates of methylcarbamate
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316161 Novel antiviral compounds
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012US20120315661 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
12/13/2012CA2836227A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012CA2833507A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/12/2012EP2532664A1 Substituted indolo [2,3-a] quinolizines in the treatment of cancer
12/12/2012EP2532663A1 Naphthalenecarboxylic acid derivatives and their use as semiconductors
12/12/2012EP2532657A2 Compounds and methods of use
12/12/2012EP2532656A1 Gpr119 agonist
12/12/2012EP2531506A1 S piroindoline compounds for use as anthelminthi cs
12/12/2012EP2531505A1 Process for producing 3,7-diaza-bicyclo[3.3.1]nonane-metal complexes
12/12/2012EP2531504A1 Method for producing 3,7-diaza-bicyclo[3.3.1]nonane-metal complex solutions
12/12/2012EP2531503A1 Gamma secretase modulaters
12/12/2012EP2531502A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
12/12/2012EP2531501A1 Apoptosis signal-regulating kinase 1 inhibitors
12/12/2012EP2531500A1 Hetaryl-[1,8]naphthyridine derivatives
12/12/2012EP2531498A1 Compounds and compositions as protein kinase inhibitors
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 646